Incyte Corporation (INCY)
USD 60.96
(-2.4%)
USD 60.96
(-2.4%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 8.25% |
| 2022 | 1.47 Billion USD | 26.43% |
| 2021 | 1.16 Billion USD | 22.5% |
| 2020 | 949.65 Million USD | 14.64% |
| 2019 | 828.34 Million USD | 15.08% |
| 2018 | 719.79 Million USD | 7.12% |
| 2017 | 671.95 Million USD | -44.88% |
| 2016 | 1.21 Billion USD | 45.78% |
| 2015 | 836.28 Million USD | 0.75% |
| 2014 | 830.06 Million USD | 31.85% |
| 2013 | 629.56 Million USD | 90.54% |
| 2012 | 330.41 Million USD | -40.58% |
| 2011 | 556.03 Million USD | -3.84% |
| 2010 | 578.22 Million USD | -29.03% |
| 2009 | 814.77 Million USD | 79.81% |
| 2008 | 453.13 Million USD | 4.12% |
| 2007 | 435.21 Million USD | -0.75% |
| 2006 | 438.51 Million USD | 11.44% |
| 2005 | 393.5 Million USD | -10.24% |
| 2004 | 438.4 Million USD | 94.66% |
| 2003 | 225.21 Million USD | -9.82% |
| 2002 | 249.72 Million USD | -5.89% |
| 2001 | 265.35 Million USD | 0.47% |
| 2000 | 264.12 Million USD | 411.87% |
| 1999 | 51.6 Million USD | 1.78% |
| 1998 | 50.7 Million USD | 7.64% |
| 1997 | 47.1 Million USD | 117.05% |
| 1996 | 21.7 Million USD | 97.27% |
| 1995 | 11 Million USD | 134.04% |
| 1994 | 4.7 Million USD | 213.33% |
| 1993 | 1.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.74 Billion USD | 9.36% |
| 2024 Q3 | 1.84 Billion USD | 10.6% |
| 2024 Q2 | 1.66 Billion USD | -4.4% |
| 2023 Q2 | 1.46 Billion USD | 9.93% |
| 2023 FY | 1.59 Billion USD | 8.25% |
| 2023 Q3 | 1.45 Billion USD | -0.73% |
| 2023 Q4 | 1.59 Billion USD | 9.3% |
| 2023 Q1 | 1.33 Billion USD | -9.23% |
| 2022 Q3 | 1.28 Billion USD | 4.02% |
| 2022 Q2 | 1.23 Billion USD | 3.6% |
| 2022 FY | 1.47 Billion USD | 26.43% |
| 2022 Q4 | 1.47 Billion USD | 14.59% |
| 2022 Q1 | 1.19 Billion USD | 2.39% |
| 2021 Q1 | 933.59 Million USD | -1.69% |
| 2021 Q4 | 1.16 Billion USD | 10.78% |
| 2021 FY | 1.16 Billion USD | 22.5% |
| 2021 Q3 | 1.05 Billion USD | 8.4% |
| 2021 Q2 | 968.76 Million USD | 3.77% |
| 2020 FY | 949.65 Million USD | 14.64% |
| 2020 Q4 | 949.65 Million USD | 3.61% |
| 2020 Q1 | 814.7 Million USD | -1.65% |
| 2020 Q3 | 916.59 Million USD | 5.63% |
| 2020 Q2 | 867.71 Million USD | 6.51% |
| 2019 FY | 828.34 Million USD | 15.08% |
| 2019 Q1 | 668.59 Million USD | -7.11% |
| 2019 Q2 | 700.44 Million USD | 4.76% |
| 2019 Q3 | 792.29 Million USD | 13.11% |
| 2019 Q4 | 828.34 Million USD | 4.55% |
| 2018 Q1 | 677.96 Million USD | 0.9% |
| 2018 Q3 | 717.04 Million USD | 7.95% |
| 2018 Q4 | 719.79 Million USD | 0.38% |
| 2018 FY | 719.79 Million USD | 7.12% |
| 2018 Q2 | 664.23 Million USD | -2.03% |
| 2017 Q2 | 612.6 Million USD | -4.49% |
| 2017 Q3 | 616.55 Million USD | 0.64% |
| 2017 Q4 | 671.95 Million USD | 8.99% |
| 2017 Q1 | 641.41 Million USD | -47.39% |
| 2017 FY | 671.95 Million USD | -44.88% |
| 2016 Q2 | 1.12 Billion USD | 27.93% |
| 2016 Q3 | 1.17 Billion USD | 4.75% |
| 2016 Q4 | 1.21 Billion USD | 3.83% |
| 2016 FY | 1.21 Billion USD | 45.78% |
| 2016 Q1 | 876.19 Million USD | 4.77% |
| 2015 Q1 | 904.03 Million USD | 8.91% |
| 2015 FY | 836.28 Million USD | 0.75% |
| 2015 Q4 | 836.28 Million USD | -0.82% |
| 2015 Q2 | 875.16 Million USD | -3.19% |
| 2015 Q3 | 843.19 Million USD | -3.65% |
| 2014 Q4 | 830.06 Million USD | -5.12% |
| 2014 Q1 | 666.82 Million USD | 5.92% |
| 2014 FY | 830.06 Million USD | 31.85% |
| 2014 Q3 | 874.85 Million USD | 2.91% |
| 2014 Q2 | 850.1 Million USD | 27.49% |
| 2013 Q4 | 629.56 Million USD | 91.59% |
| 2013 FY | 629.56 Million USD | 90.54% |
| 2013 Q2 | 362 Million USD | -26.69% |
| 2013 Q1 | 493.8 Million USD | 49.45% |
| 2013 Q3 | 328.6 Million USD | -9.23% |
| 2012 Q3 | 516.48 Million USD | -2.4% |
| 2012 FY | 330.41 Million USD | -40.58% |
| 2012 Q2 | 529.15 Million USD | -2.45% |
| 2012 Q1 | 542.45 Million USD | -2.44% |
| 2012 Q4 | 330.41 Million USD | -36.03% |
| 2011 Q2 | 552.94 Million USD | -1.89% |
| 2011 Q3 | 552.24 Million USD | -0.13% |
| 2011 Q4 | 556.03 Million USD | 0.69% |
| 2011 FY | 556.03 Million USD | -3.84% |
| 2011 Q1 | 563.58 Million USD | -2.53% |
| 2010 Q3 | 593.54 Million USD | -0.82% |
| 2010 Q1 | 617.07 Million USD | -24.26% |
| 2010 Q2 | 598.46 Million USD | -3.02% |
| 2010 FY | 578.22 Million USD | -29.03% |
| 2010 Q4 | 578.22 Million USD | -2.58% |
| 2009 Q4 | 814.77 Million USD | 21.22% |
| 2009 FY | 814.77 Million USD | 79.81% |
| 2009 Q1 | 446.38 Million USD | -1.49% |
| 2009 Q2 | 450.44 Million USD | 0.91% |
| 2009 Q3 | 672.17 Million USD | 49.22% |
| 2008 Q3 | 442.09 Million USD | 0.04% |
| 2008 Q4 | 453.13 Million USD | 2.5% |
| 2008 Q2 | 441.93 Million USD | 1.81% |
| 2008 Q1 | 434.05 Million USD | -0.26% |
| 2008 FY | 453.13 Million USD | 4.12% |
| 2007 Q4 | 435.21 Million USD | 2.61% |
| 2007 Q2 | 428.43 Million USD | -0.23% |
| 2007 FY | 435.21 Million USD | -0.75% |
| 2007 Q3 | 424.15 Million USD | -1.0% |
| 2007 Q1 | 429.41 Million USD | -2.08% |
| 2006 FY | 438.51 Million USD | 11.44% |
| 2006 Q3 | 531.03 Million USD | 23.54% |
| 2006 Q1 | 436.52 Million USD | 10.93% |
| 2006 Q4 | 438.51 Million USD | -17.42% |
| 2006 Q2 | 429.83 Million USD | -1.53% |
| 2005 FY | 393.5 Million USD | -10.24% |
| 2005 Q2 | 402.89 Million USD | -5.78% |
| 2005 Q1 | 427.59 Million USD | -2.47% |
| 2005 Q3 | 394.59 Million USD | -2.06% |
| 2005 Q4 | 393.5 Million USD | -0.28% |
| 2004 Q2 | 485.48 Million USD | 4.48% |
| 2004 Q1 | 464.65 Million USD | 106.32% |
| 2004 FY | 438.4 Million USD | 94.66% |
| 2004 Q4 | 438.4 Million USD | -0.31% |
| 2004 Q3 | 439.74 Million USD | -9.42% |
| 2003 Q4 | 225.21 Million USD | 1.73% |
| 2003 Q3 | 221.37 Million USD | -5.04% |
| 2003 FY | 225.21 Million USD | -9.82% |
| 2003 Q1 | 232.86 Million USD | -6.75% |
| 2003 Q2 | 233.11 Million USD | 0.11% |
| 2002 Q1 | 245.43 Million USD | -7.51% |
| 2002 Q4 | 249.72 Million USD | 7.38% |
| 2002 FY | 249.72 Million USD | -5.89% |
| 2002 Q3 | 232.57 Million USD | -3.68% |
| 2002 Q2 | 241.46 Million USD | -1.62% |
| 2001 Q2 | 247.77 Million USD | 2.43% |
| 2001 Q4 | 265.35 Million USD | 9.56% |
| 2001 FY | 265.35 Million USD | 0.47% |
| 2001 Q3 | 242.2 Million USD | -2.25% |
| 2001 Q1 | 241.88 Million USD | -8.42% |
| 2000 FY | 264.12 Million USD | 411.87% |
| 2000 Q2 | 274.69 Million USD | 1.22% |
| 2000 Q4 | 264.12 Million USD | 3.0% |
| 2000 Q3 | 256.43 Million USD | -6.65% |
| 2000 Q1 | 271.37 Million USD | 425.91% |
| 1999 FY | 51.6 Million USD | 1.78% |
| 1999 Q1 | 73.2 Million USD | 44.38% |
| 1999 Q2 | 53.3 Million USD | -27.19% |
| 1999 Q3 | 44.1 Million USD | -17.26% |
| 1999 Q4 | 51.6 Million USD | 17.01% |
| 1998 Q3 | 57.3 Million USD | -6.53% |
| 1998 Q4 | 50.7 Million USD | -11.52% |
| 1998 Q2 | 61.3 Million USD | -9.59% |
| 1998 Q1 | 67.8 Million USD | 43.95% |
| 1998 FY | 50.7 Million USD | 7.64% |
| 1997 Q2 | 27.1 Million USD | -18.62% |
| 1997 FY | 47.1 Million USD | 117.05% |
| 1997 Q4 | 47.1 Million USD | 17.75% |
| 1997 Q1 | 33.3 Million USD | 53.46% |
| 1997 Q3 | 40 Million USD | 47.6% |
| 1996 FY | 21.7 Million USD | 97.27% |
| 1996 Q1 | 17.2 Million USD | 56.36% |
| 1996 Q2 | 22.6 Million USD | 31.4% |
| 1996 Q3 | 29.9 Million USD | 32.3% |
| 1996 Q4 | 21.7 Million USD | -27.42% |
| 1995 Q2 | 3.8 Million USD | -19.15% |
| 1995 FY | 11 Million USD | 134.04% |
| 1995 Q3 | 3.6 Million USD | -5.26% |
| 1995 Q4 | 11 Million USD | 205.56% |
| 1995 Q1 | 4.7 Million USD | 0.0% |
| 1994 FY | 4.7 Million USD | 213.33% |
| 1994 Q1 | 1.3 Million USD | -13.33% |
| 1994 Q2 | 1.7 Million USD | 30.77% |
| 1994 Q3 | 1.5 Million USD | -11.76% |
| 1994 Q4 | 4.7 Million USD | 213.33% |
| 1993 Q4 | 1.5 Million USD | 36.36% |
| 1993 Q3 | 1.1 Million USD | 0.0% |
| 1993 FY | 1.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -374.206% |
| Alkermes plc | 933.53 Million USD | -70.563% |
| Agenus Inc. | 462.29 Million USD | -244.427% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 60.69% |
| Aptorum Group Limited | 5.25 Million USD | -30190.077% |
| Ardelyx, Inc. | 130.76 Million USD | -1117.676% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -232.839% |
| Bicycle Therapeutics plc | 224.41 Million USD | -609.53% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1122.848% |
| ChromaDex Corporation | 26.5 Million USD | -5906.753% |
| Chimerix, Inc. | 19.74 Million USD | -7964.168% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -4426.437% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2094.207% |
| CRISPR Therapeutics AG | 346.76 Million USD | -359.174% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1029.911% |
| Dyadic International, Inc. | 2.34 Million USD | -67926.801% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -9690.752% |
| Fortress Biotech, Inc. | 165.93 Million USD | -859.551% |
| Lantern Pharma Inc. | 2.73 Million USD | -58018.789% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2127.574% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -45023.097% |
| IO Biotech, Inc. | 17.55 Million USD | -8969.663% |
| Jaguar Health, Inc. | 45.86 Million USD | -3371.569% |
| Novavax, Inc. | 2.57 Billion USD | 38.099% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -4315.858% |
| Opthea Limited | 264.6 Million USD | -501.762% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1118.198% |
| ContextLogic Inc. | 206 Million USD | -672.947% |
| MiMedx Group, Inc. | 96.33 Million USD | -1552.933% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3215.709% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -45021.025% |
| NextCure, Inc. | 14.99 Million USD | -10517.257% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -39293.122% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -23747.087% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3306.727% |
| Vaxcyte, Inc. | 167.44 Million USD | -850.898% |
| PDS Biotechnology Corporation | 33.25 Million USD | -4687.467% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -576.945% |
| Pharming Group N.V. | 244.07 Million USD | -552.374% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -13255.729% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1145.995% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23998.725% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23998.725% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1831.593% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -23869.14% |
| Acelyrin, Inc. | 86.35 Million USD | -1743.908% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -122453.86% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -10973.58% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1171.202% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -16697.869% |
| Senti Biosciences, Inc. | 52.57 Million USD | -2928.799% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2215.12% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -950.92% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -81304.397% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -119120.794% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -601.96% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -16898.719% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -600.068% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -221.99% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -14489.243% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -5687.758% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -13054.148% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -227.223% |
| Immix Biopharma, Inc. | 3.72 Million USD | -42682.451% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4111.018% |
| MEI Pharma, Inc. | 8.35 Million USD | -18957.69% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -5387.748% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -358.102% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -991.575% |
| Fortress Biotech, Inc. | 165.93 Million USD | -859.551% |
| Precigen, Inc. | 41.64 Million USD | -3723.528% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3089.005% |
| AlloVir, Inc. | 45.01 Million USD | -3437.199% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1121.656% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1055.493% |
| ImmuCell Corporation | 18.81 Million USD | -8362.758% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -5541.146% |
| Onconetix, Inc. | 23.18 Million USD | -6768.891% |
| PureTech Health plc | 125.58 Million USD | -1167.903% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -17690.726% |
| Elevation Oncology, Inc. | 34.28 Million USD | -4544.624% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -65023.517% |
| Seer, Inc. | 39.36 Million USD | -3944.888% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2475.072% |
| Innoviva, Inc. | 568.55 Million USD | -180.057% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -5747.914% |
| ESSA Pharma Inc. | 3.49 Million USD | -45457.587% |
| GlycoMimetics, Inc. | 6.9 Million USD | -22969.443% |
| GT Biopharma, Inc. | 6.63 Million USD | -23905.277% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -502.243% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -484.776% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1794.973% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -16190.874% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -5760.613% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -49260.882% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2058.513% |
| Aptose Biosciences Inc. | 15.8 Million USD | -9972.112% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -14323.146% |
| Soligenix, Inc. | 7.27 Million USD | -21787.162% |
| Century Therapeutics, Inc. | 175.94 Million USD | -805.002% |
| Kura Oncology, Inc. | 51.66 Million USD | -2982.091% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1212.866% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -38425.768% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -23974.764% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -530.357% |
| Autolus Therapeutics plc | 263.9 Million USD | -503.345% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -15090.517% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1691.866% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3295.104% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -351.252% |
| GRI Bio, Inc. | 2.69 Million USD | -58938.561% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -196577.31% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -5021.321% |
| IGM Biosciences, Inc. | 220.17 Million USD | -623.177% |
| INmune Bio, Inc. | 18.86 Million USD | -8341.682% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -520.819% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5876.583% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -58473.664% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -48440.881% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -2623.924% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1555.872% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -501.458% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -93.465% |
| Verastem, Inc. | 71.18 Million USD | -2136.806% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3137.901% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -4027.404% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3154.046% |
| Histogen Inc. | 5.69 Million USD | -27849.272% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -36206.735% |
| Surrozen, Inc. | 8.14 Million USD | -19449.048% |
| Organovo Holdings, Inc. | 2.74 Million USD | -57842.868% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -507221.782% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2731.714% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -9543.108% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -3015.805% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -192464.777% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1156.477% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -14624.712% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -955.259% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -60968.635% |
| Apollomics, Inc. | 14.15 Million USD | -11150.406% |
| Amarin Corporation plc | 279.58 Million USD | -469.508% |
| Mesoblast Limited | 188.79 Million USD | -743.372% |
| Turnstone Biologics Corp. | 14.14 Million USD | -11154.382% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -780.739% |
| Synaptogenix, Inc. | 5.52 Million USD | -28696.074% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -23851.113% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -836.035% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18507.387% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -90504.094% |
| Exelixis, Inc. | 678.44 Million USD | -134.694% |
| Better Therapeutics, Inc. | 23.84 Million USD | -6578.425% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -870.624% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -167.965% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14808.61% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -97969.371% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -3990.4% |
| Gritstone bio, Inc. | 125.91 Million USD | -1164.519% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10749.482% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -31190.759% |
| Avid Bioservices, Inc. | 275.66 Million USD | -477.604% |
| Insmed Incorporated | 1.66 Billion USD | 4.182% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -20594.893% |
| MediWound Ltd. | 27.18 Million USD | -5756.733% |
| OmniAb, Inc. | 87.4 Million USD | -1721.819% |
| Alector, Inc. | 487.66 Million USD | -226.506% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -294.658% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -8541.9% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -4049.454% |
| Zai Lab Limited | 240.17 Million USD | -562.957% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -152.718% |
| Aura Biosciences, Inc. | 29.22 Million USD | -5347.942% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1574.716% |
| Immunic, Inc. | 25.36 Million USD | -6176.687% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2199.772% |
| Veracyte, Inc. | 93.71 Million USD | -1598.983% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -60750.936% |
| FibroGen, Inc. | 585.72 Million USD | -171.845% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9059.926% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -243710.828% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -28054.572% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 79.203% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -19322.664% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1795.063% |
| TG Therapeutics, Inc. | 169.08 Million USD | -841.698% |
| Galecto, Inc. | 5.89 Million USD | -26905.936% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -19121.028% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 39.189% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -5424.495% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -12516.037% |
| XBiotech Inc. | 8.39 Million USD | -18862.368% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10749.482% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -2894.114% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -338.514% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -5822.742% |
| Theravance Biopharma, Inc. | 169 Million USD | -842.149% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -30.986% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -218.183% |
| Vaxxinity, Inc. | 30.94 Million USD | -5045.65% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -63.732% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -26300.958% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -113.66% |
| NexImmune, Inc. | 5.08 Million USD | -31217.808% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -428627.982% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -51683.698% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 77.596% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -30793.689% |
| Scopus BioPharma Inc. | 7.45 Million USD | -21260.039% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -5955.64% |
| Ainos, Inc. | 7.39 Million USD | -21433.973% |
| Pluri Inc. | 34.11 Million USD | -4567.771% |
| Prothena Corporation plc | 135.01 Million USD | -1079.311% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -554.978% |
| Celularity Inc. | 102.92 Million USD | -1446.96% |
| Rallybio Corporation | 9.43 Million USD | -16774.417% |
| Cue Biopharma, Inc. | 24.44 Million USD | -6413.684% |
| MeiraGTx Holdings plc | 319.99 Million USD | -397.598% |
| Omeros Corporation | 403.25 Million USD | -294.857% |
| Humacyte, Inc. | 114.67 Million USD | -1288.482% |
| Immunocore Holdings plc | 228.15 Million USD | -597.88% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -32561.949% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1974.889% |
| Blueprint Medicines Corporation | 918.64 Million USD | -73.329% |
| CalciMedica, Inc. | 4.02 Million USD | -39430.04% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -9023.711% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -932.982% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1755.425% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -473.186% |
| Pulmatrix, Inc. | 15.96 Million USD | -9874.754% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -9994.909% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -6371.064% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -534.856% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -3035.253% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -31.523% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -4909.817% |
| Nutriband Inc. | 1.07 Million USD | -147480.124% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -14874.795% |
| Vor Biopharma Inc. | 59.1 Million USD | -2594.014% |
| Roivant Sciences Ltd. | 773.95 Million USD | -105.732% |
| Evogene Ltd. | 17.99 Million USD | -8750.862% |
| ProKidney Corp. | 29.21 Million USD | -5349.993% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2112.131% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -225759.347% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 15.705% |
| CorMedix Inc. | 11.91 Million USD | -13260.741% |
| BioLineRx Ltd. | 50.7 Million USD | -3040.448% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -965.356% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1700.375% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3138.823% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -5011.243% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -8764.659% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1177.536% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -28061.832% |
| MediciNova, Inc. | 3.89 Million USD | -40816.056% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -8610.925% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -105752.054% |
| GeoVax Labs, Inc. | 3.51 Million USD | -45136.472% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -300.814% |
| Biomea Fusion, Inc. | 30.69 Million USD | -5088.237% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 41.498% |
| Mereo BioPharma Group plc | 15.96 Million USD | -9875.379% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -5003.266% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -2613.295% |
| Absci Corporation | 58.3 Million USD | -2630.979% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8259.25% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -4866.222% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2057.84% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1720.091% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -4615.043% |
| Allakos Inc. | 74.79 Million USD | -2028.902% |
| Imunon, Inc. | 8.53 Million USD | -18565.771% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -6976.441% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1286.85% |
| BioAtla, Inc. | 48.98 Million USD | -3150.459% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14808.61% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -57196.51% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1119.159% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -11101.337% |
| XOMA Corporation | 145.58 Million USD | -993.742% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -4629.749% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2215.726% |
| aTyr Pharma, Inc. | 31.59 Million USD | -4939.308% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2475.53% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -3441.132% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3189.678% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -55379.791% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -19417.853% |
| Akari Therapeutics, Plc | 4.58 Million USD | -34635.384% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8879.069% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 3.467% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -394116.01% |
| UroGen Pharma Ltd. | 243.52 Million USD | -553.848% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -395.9% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -57558.394% |
| Orgenesis Inc. | 35.53 Million USD | -4380.85% |
| Entera Bio Ltd. | 1.37 Million USD | -115365.555% |
| GH Research PLC | 6.7 Million USD | -23661.677% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -23315.735% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -8357.824% |
| Xencor, Inc. | 283.55 Million USD | -461.53% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -53230.319% |
| Replimune Group, Inc. | 113.21 Million USD | -1306.425% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -42280.011% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1437.979% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -394116.01% |
| Portage Biotech Inc. | 4.45 Million USD | -35681.348% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -105752.054% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -6807.896% |
| OncoCyte Corporation | 49.29 Million USD | -3129.888% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -38390.333% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -199561.686% |
| Purple Biotech Ltd. | 10 Million USD | -15814.743% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -27419.357% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2680.723% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -12753.304% |
| HilleVax, Inc. | 78.9 Million USD | -1917.856% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -31430.099% |
| Tharimmune, Inc. | 1.81 Million USD | -87626.151% |
| Genprex, Inc. | 3.25 Million USD | -48829.571% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -5771.419% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -30310.046% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -772846.602% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -443988.379% |
| OKYO Pharma Limited | 7.42 Million USD | -21356.718% |
| Savara Inc. | 37.19 Million USD | -4181.216% |
| Curis, Inc. | 57.61 Million USD | -2663.782% |
| Daré Bioscience, Inc. | 26.32 Million USD | -5947.394% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -3961.935% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -110168.006% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -7548.158% |
| BeiGene, Ltd. | 2.23 Billion USD | 28.717% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -7379.028% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -506.817% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -7384.582% |
| Erasca, Inc. | 78.61 Million USD | -1925.505% |
| bluebird bio, Inc. | 424.62 Million USD | -274.984% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -242901.166% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 15.755% |
| DBV Technologies S.A. | 42.8 Million USD | -3620.257% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -242901.166% |
| Moderna, Inc. | 4.57 Billion USD | 65.173% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -22662.974% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -96051.57% |
| Molecular Templates, Inc. | 31.17 Million USD | -5008.177% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -9227.885% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -170.747% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1178.88% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -5703.368% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -4267.649% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2761.993% |
| MacroGenics, Inc. | 154.2 Million USD | -932.554% |
| RenovoRx, Inc. | 4.46 Million USD | -35553.157% |
| Adicet Bio, Inc. | 37.12 Million USD | -4189.52% |
| Prime Medicine, Inc. | 60.78 Million USD | -2519.727% |
| Aditxt, Inc. | 28.53 Million USD | -5480.733% |
| Adagene Inc. | 45.16 Million USD | -3425.112% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -881062.805% |
| Quantum-Si incorporated | 26.63 Million USD | -5879.009% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -128.261% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -52235.331% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1285.052% |
| SciSparc Ltd. | 1.59 Million USD | -99728.84% |
| Vericel Corporation | 127.7 Million USD | -1146.835% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -28512.764% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1765.4% |
| Generation Bio Co. | 171.63 Million USD | -827.734% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -13685.887% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -3706.435% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -530.108% |
| Invivyd, Inc. | 51.71 Million USD | -2979.052% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1631.161% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -24376.688% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -2009.079% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -155852.008% |
| 2seventy bio, Inc. | 310.12 Million USD | -413.427% |
| ADMA Biologics, Inc. | 193.97 Million USD | -720.859% |
| Clene Inc. | 38.95 Million USD | -3987.88% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -4306.709% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -519.618% |
| GeoVax Labs, Inc. | 3.51 Million USD | -45136.472% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -736.878% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -12973.187% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -702.871% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -12956.959% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3209.576% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -2913.323% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -330.513% |
| Evaxion Biotech A/S | 17.61 Million USD | -8938.012% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -889.424% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -939.436% |
| Trevena, Inc. | 48.26 Million USD | -3199.221% |
| Surrozen, Inc. | 8.14 Million USD | -19449.048% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -7273.327% |
| Cingulate Inc. | 10.36 Million USD | -15268.118% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -57800.727% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4169.736% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -44295.96% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -12008.517% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -401.975% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -6307.783% |
| Clearmind Medicine Inc. | 3.61 Million USD | -44007.104% |
| Kronos Bio, Inc. | 54.2 Million USD | -2837.713% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3284.712% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6895.996% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -7833.187% |
| Statera Biopharma, Inc. | 22.67 Million USD | -6921.689% |
| ImmunityBio, Inc. | 1.09 Billion USD | -46.028% |
| Korro Bio, Inc. | 51.75 Million USD | -2976.731% |
| Kineta, Inc. | 7.22 Million USD | -21947.494% |
| BioVie Inc. | 9.7 Million USD | -16311.551% |
| Codexis, Inc. | 49.94 Million USD | -3087.983% |
| Celularity Inc. | 102.92 Million USD | -1446.96% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1554.358% |
| Celcuity Inc. | 51.45 Million USD | -2994.786% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -461168.156% |
| Cibus, Inc. | 206.11 Million USD | -672.508% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -3648.723% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -5945.294% |
| IN8bio, Inc. | 8.77 Million USD | -18051.733% |
| Kodiak Sciences Inc. | 213.59 Million USD | -645.476% |
| Annexon, Inc. | 47.11 Million USD | -3279.324% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1678.258% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1552.212% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -11531.748% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 38.838% |
| Eyenovia, Inc. | 19.78 Million USD | -7949.785% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -799.151% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20629.983% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -6507.204% |
| Arcellx, Inc. | 339.75 Million USD | -368.657% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -13282.669% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -548.477% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -16550.319% |
| Moolec Science SA | 13.94 Million USD | -11317.923% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -3589.91% |
| Geron Corporation | 146.12 Million USD | -989.648% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -3051.013% |
| Royalty Pharma plc | 6.29 Billion USD | 74.716% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -3903.092% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -540741.559% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -64619.004% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -741.776% |
| Humacyte, Inc. | 114.67 Million USD | -1288.482% |
| Structure Therapeutics Inc. | 29.05 Million USD | -5380.946% |
| 89bio, Inc. | 59.96 Million USD | -2555.421% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -5916.967% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -133032.943% |
| Genelux Corporation | 8.42 Million USD | -18810.57% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -23124.475% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1068.047% |
| Notable Labs, Ltd. | 4.42 Million USD | -35867.246% |
| Liquidia Corporation | 73.13 Million USD | -2077.076% |
| Mustang Bio, Inc. | 17.61 Million USD | -8937.233% |
| Immunovant, Inc. | 48.95 Million USD | -3152.518% |
| Quantum-Si incorporated | 26.63 Million USD | -5879.009% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -4048.373% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -51213.89% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2055.766% |
| Acasti Pharma Inc. | 11.55 Million USD | -13677.537% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -6943.034% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -58473.664% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -4217.786% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -116734.527% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -26019.915% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -6311.395% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -6767.969% |
| PepGen Inc. | 34.63 Million USD | -4497.817% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -13011.578% |
| United Therapeutics Corporation | 1.18 Billion USD | -34.687% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -22698.826% |
| Solid Biosciences Inc. | 38.45 Million USD | -4040.283% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18507.387% |
| Immuneering Corporation | 12 Million USD | -13159.685% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -507221.782% |
| Silo Pharma, Inc. | 1.56 Million USD | -101365.65% |
| Belite Bio, Inc | 4.21 Million USD | -37712.159% |
| XOMA Corporation | 145.58 Million USD | -993.742% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -65479.489% |
| Bionomics Limited | 10.15 Million USD | -15573.922% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -7309.008% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6849.199% |
| uniQure N.V. | 624.01 Million USD | -155.164% |
| Cassava Sciences, Inc. | 14.19 Million USD | -11117.119% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -881062.805% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -835.617% |
| Forte Biosciences, Inc. | 3.66 Million USD | -43333.442% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -610941.396% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -23499.674% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20629.983% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9059.926% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -14966.9% |
| Altimmune, Inc. | 16.54 Million USD | -9526.202% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -157.771% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6849.199% |
| Compugen Ltd. | 55.77 Million USD | -2754.81% |
| Peak Bio, Inc. | 20.75 Million USD | -7572.347% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1341.451% |
| Benitec Biopharma Inc. | 4.96 Million USD | -31989.279% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -908.768% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -2018.113% |
| Zura Bio Limited | 21.29 Million USD | -7378.255% |
| PolyPid Ltd. | 17.46 Million USD | -9015.354% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1316.623% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -2018.113% |
| Instil Bio, Inc. | 99.8 Million USD | -1495.445% |
| argenx SE | 444.95 Million USD | -257.853% |
| Immunome, Inc. | 28.65 Million USD | -5456.11% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -18998.837% |
| Verona Pharma plc | 58.84 Million USD | -2606.055% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -10901.658% |
| Shattuck Labs, Inc. | 14.85 Million USD | -10615.862% |
| CervoMed Inc. | 2.59 Million USD | -61241.494% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -32568.65% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -12402.12% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -15014.096% |
| Moolec Science SA | 13.94 Million USD | -11317.923% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -67843.985% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2764.037% |
| AnaptysBio, Inc. | 364.28 Million USD | -337.093% |
| Design Therapeutics, Inc. | 11.95 Million USD | -13217.748% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -12453.374% |
| NeurAxis, Inc. | 1.91 Million USD | -83145.545% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -3990.295% |
| Lumos Pharma, Inc. | 13.33 Million USD | -11842.324% |
| Achilles Therapeutics plc | 19.08 Million USD | -8242.17% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -10901.658% |
| 180 Life Sciences Corp. | 5.38 Million USD | -29456.492% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -6650.342% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6895.996% |
| Nutriband Inc. | 1.07 Million USD | -147480.124% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -5103.837% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -10872.848% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -296.804% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -4803.366% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -12102.148% |
| Palisade Bio, Inc. | 2.73 Million USD | -58033.26% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -30211.631% |
| Beam Therapeutics Inc. | 478.38 Million USD | -232.843% |
| Neurogene Inc. | 36.54 Million USD | -4256.535% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -300.117% |
| AEON Biopharma, Inc. | 159.88 Million USD | -895.86% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3241.595% |
| Sesen Bio, Inc. | 30.98 Million USD | -5039.007% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -6033.315% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -20844.814% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -713.47% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -729.061% |
| Athira Pharma, Inc. | 30.05 Million USD | -5197.501% |
| Vaccinex, Inc. | 5.94 Million USD | -26696.87% |
| HCW Biologics Inc. | 15.05 Million USD | -10478.501% |
| XOMA Corporation | 145.58 Million USD | -993.742% |
| Nektar Therapeutics | 267.04 Million USD | -496.253% |
| Arvinas, Inc. | 644.6 Million USD | -147.017% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8879.069% |
| Merus N.V. | 102.15 Million USD | -1458.741% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -987.988% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1573.959% |
| Rezolute, Inc. | 11.73 Million USD | -13469.712% |
| Clene Inc. | 38.95 Million USD | -3987.88% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -55820.53% |
| BeyondSpring Inc. | 48.26 Million USD | -3198.742% |
| Synlogic, Inc. | 32.89 Million USD | -4740.462% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -10796.257% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -97346.144% |
| Peak Bio, Inc. | 20.75 Million USD | -7572.347% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2409.132% |
| Krystal Biotech, Inc. | 39.71 Million USD | -3909.342% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -322.752% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1499.162% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -367862.637% |
| MannKind Corporation | 721.36 Million USD | -120.73% |
| Ikena Oncology, Inc. | 22.33 Million USD | -7029.035% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -76231.256% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1452.071% |
| Gossamer Bio, Inc. | 249.14 Million USD | -539.089% |
| CohBar, Inc. | 1.03 Million USD | -153945.227% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -14796.342% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8259.25% |
| Legend Biotech Corporation | 589.93 Million USD | -169.907% |
| Mural Oncology plc | 37.92 Million USD | -4098.139% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1100.481% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -69269.921% |
| Disc Medicine, Inc. | 22.87 Million USD | -6860.743% |
| Champions Oncology, Inc. | 28.03 Million USD | -5579.579% |
| REGENXBIO Inc. | 262.22 Million USD | -507.208% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -47298.129% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -12603.606% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -11754.632% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -7408.937% |
| Vaxart, Inc. | 34.02 Million USD | -4579.706% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -7709.355% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -5480.67% |
| Cellectis S.A. | 249.57 Million USD | -537.993% |
| Longeveron Inc. | 5.33 Million USD | -29734.551% |
| Repare Therapeutics Inc. | 41.81 Million USD | -3707.528% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 33.8% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -2537.606% |
| Revolution Medicines, Inc. | 262.39 Million USD | -506.817% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -75470.479% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -18358.961% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -13392.67% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -11238.532% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -73924.64% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 69.081% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1194.918% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -28512.764% |
| Veru Inc. | 32.81 Million USD | -4752.602% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -23080.521% |
| Cingulate Inc. | 10.36 Million USD | -15268.118% |
| Passage Bio, Inc. | 39.26 Million USD | -3955.499% |
| Context Therapeutics Inc. | 4.19 Million USD | -37886.123% |
| Exicure, Inc. | 8.54 Million USD | -18525.219% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -5296.062% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -15084.722% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -7124.128% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -876.937% |
| Nuvalent, Inc. | 31.82 Million USD | -4903.519% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -24929.289% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2426.53% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -8745.944% |
| OmniAb, Inc. | 87.4 Million USD | -1721.819% |
| Anew Medical, Inc. | 8.24 Million USD | -19219.447% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -4058.547% |
| Lipocine Inc. | 2.63 Million USD | -60405.109% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -5960.711% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -3859.689% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5876.583% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1748.167% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -29381.022% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1824.263% |
| Ocugen, Inc. | 23.98 Million USD | -6539.161% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3331.099% |
| Q32 Bio Inc. | 233.12 Million USD | -583.002% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -17463.093% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2876.094% |
| Equillium, Inc. | 27.95 Million USD | -5595.425% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -670.732% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -28198.646% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -25862.47% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -912.083% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2193.247% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -15863.885% |
| Dominari Holdings Inc. | 4.63 Million USD | -34253.182% |
| Edesa Biotech, Inc. | 1.84 Million USD | -86359.492% |
| vTv Therapeutics Inc. | 29.56 Million USD | -5285.294% |
| Bio-Techne Corporation | 744.34 Million USD | -113.917% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1162.714% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -362.256% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -3824.264% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -5398.74% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1623.982% |
| Nkarta, Inc. | 105.6 Million USD | -1407.831% |
| BioCardia, Inc. | 4.59 Million USD | -34589.978% |
| Iterum Therapeutics plc | 32.66 Million USD | -4774.992% |